Merit Medical Systems (MMSI) Fundamentals 2026 — P/E 31.1x, Revenue Analysis | SniperIQ
Merit Medical Systems (MMSI) is a US-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of $4.4B, trading at $72.98 on the NASDAQ. This SniperIQ fundamentals page covers Merit Medical Systems's valuation (P/E 31.1x, P/B 2.7x), profitability (net margin 9.0%), revenue (
.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap$4.4B
P/E (TTM)31.1x
Net Margin9.0%
Revenue (FY25)
.5B
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Merit Medical Systems's market cap?
Merit Medical Systems (MMSI) has a market capitalization of approximately $4.4B, trading at $72.98 on the NASDAQ. Market cap moves with the live share price.
What is Merit Medical Systems's P/E ratio?
Merit Medical Systems's trailing twelve-month P/E ratio is 31.1x, with a price-to-book (P/B) of 2.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Merit Medical Systems?
Merit Medical Systems runs a net profit margin of 9.0%, a gross margin of 48.7%, and an operating margin of 12.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Merit Medical Systems generate?
Merit Medical Systems reported revenue of
.5B for fiscal year 2025, with net income of
28M and earnings per share (EPS) of 2.17. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Merit Medical Systems pay a dividend?
Merit Medical Systems does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Merit Medical Systems financially healthy?
Merit Medical Systems carries a debt-to-equity ratio of 0.51x and a current ratio of 5.08x, with a market beta of 0.51. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Merit Medical Systems a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Merit Medical Systems (MMSI) the key facts are: market cap $4.4B, P/E 31.1x, revenue
.5B, 52-week range 59.74-94.75. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Merit Medical Systems's full fundamentals live
Get Merit Medical Systems's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.